An endocrinologist with a particular interest in diabetes and obesity, Nitasha Bakhru, M.D., wants to integrate wireless technology into health care to advance personalized medicine for patients with these diseases. As a KL2 Scholar, she is investigating the use of continuous glucose monitoring to evaluate the effects of glycemic variability on epigenetic markers of pro-atherogenic gene expression. This study involves the West Wireless Health Institute as well as the Scripps Translational Science Institute and Scripps Health. She also is exploring the novel concept of a “N-of-1 trial” in personalizing anti-diabetic drug therapy based on genomic profiling.
A California native, Dr. Bakhru completed New York’s Accelerated Physician-Scientist Program, a joint venture between Renssealer Polytechnic Institute (RPI), one of the foremost technology-minded engineering schools in the country, and Albany Medical College. This program empowers clinicians with research experience. After graduating magna cum laude from RPI, and earning her M.D. in 2006, she returned to California for residency training in internal medicine at Scripps Green Hospital.
Because of her avid interest in the prevention of disease complications, and complex physiology, she chose to specialize in endocrinology and is now completing her second year of fellowship training at Scripps Clinic, Division of Diabetes & Endocrinology.